Search for: "SCHERING-PLOUGH"
Results 301 - 320
of 404
Sort by Relevance
|
Sort by Date
29 Jul 2008, 8:49 pm
. . . according to a civil suit filed by Suffolk County, New York.Here is page 25 of the complaint, click to read:This has some major implications for those to companies. [read post]
24 Jul 2008, 5:23 am
Vytorin is a drug made by a partnership of Merck & Schering-Plough. [read post]
22 Jul 2008, 3:05 pm
The Associated Press is reporting Schering-Plough and Merck's recent clinical trial fiasco involving their highly touted anti-cholesterol pill Vytorin, whereby a "European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. [read post]
21 Jul 2008, 3:49 pm
Stock down 10%, then recoups all the losses by midday, then down 15% as Vytorin, an anti-cholesterol agent jointly sold by Merck & Co. and Schering-Plough Corp., failed to show it was effective in stopping progression of a cardiac condition known as aortic stenosis, a partial blockage of the heart's aortic valve, Norwegian researchers said Monday.Whew . . . what a roller coaster . . .But there's more:There were numerically more cancer deaths in the group of… [read post]
21 Jul 2008, 11:03 am
Schering-Plough stock is down over 10% in heavy trading today.What happened? [read post]
9 Jul 2008, 11:12 am
Paul Smith, Partner at Eversheds who co-chaired the conference with Tom Sabatino, General Counsel of Schering-Plough, says, "Over the last year we've had anecdotal evidence from clients that their global demands are mushrooming, whether in Abu Dhabi or Bucharest or China. [read post]
3 Jul 2008, 7:26 pm
Regular readers know that we've been keeping two "scorecards" - one for drug preemption, and one for device preemption. [read post]
3 Jul 2008, 5:23 pm
Schering-Plough. [read post]
1 Jul 2008, 7:03 pm
We don't know for sure, but it looks as if PharmaGossip and yours truly during his writing for BrandweekNRX may have been first with this concept: Read Prominent cardiologist: Schering-Plough could have known the result of Vytorin trial before unblinding data and New evidence indicates Schering-Plough insiders knew the Vytorin trial was "a bust" on March 13, 2007 from January 30 on BrandweekNRX.By accessing this site, you are agreeing to comply with… [read post]
30 Jun 2008, 1:50 pm
Hassan should step aside and let someone who knows run Schering-Plough? [read post]
21 Jun 2008, 10:01 pm
About 90% of the attendees were the chief legal officer of their companies or just a rung or two below, representing companies such as GE, Cisco, Tyco, Schering Plough, FMC, and other major companies you've heard of. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central… [read post]
12 Jun 2008, 6:09 pm
Following only a few months after Schering-Plough's Vytoringate, here comes Pfizer's Chantixgate, unfolding at a rapid pace, day-by-day:According to ABC News, Dr. [read post]
29 May 2008, 10:26 am
Today in an SEC filing, Schering-Plough revealed that total prescriptions for disaster meds Vytorin and Zetia have dropped by more than 20% from January to April 2008.Total number of prescriptions were 3,205,000 in January and 2,492,000 in April.Most bloggers and commentators seem to think this is a dramatic drop.Reality is that Schering-Plough and Merck have so far been able to retain over 75% of their market. [read post]
28 May 2008, 1:01 pm
TODAY:Pfizer $19.30Schering-Plough $20.09Jeff Kindler: Way to go! [read post]
20 May 2008, 4:24 am
We are proud to have Fred Hassan as our CEO.Seriously, doesn't anyone at Schering-Plough realize how bad this looks? [read post]
19 May 2008, 6:56 am
Or is it the 2007 Schering-Plough proxy that is untruthful? [read post]
19 May 2008, 2:49 am
That bonus was based largely on the Vytorin-driven increase in Schering's market cap. [read post]
28 Apr 2008, 8:46 pm
Badke, Partner, Ropes & Gray LLP "Ensuring Protection and Enforcement Post-KSR," with James Gould, Legal Director, Global Patent Litigation, Schering-Plough; Kathleen Fonda, Legal Advisor, Office of Patent Legal Administration, USPTO; and Cindy Clay, Sr. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
